CTSO übertreffen die 21 der letzten 40Schätzungen.
53%
Nächster Bericht
Datum des nächsten Berichts
01. März 2026
Estimate forQ4 25(Revenue/ EPS)
$9.81M
/
-$0.04
Implizierte Änderung vonQ4 26(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+7.18%
/
-71.43%
Cytosorbents Corp. earnings per share and revenue
On 02. Jan. 2026, CTSO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 11.26 million, with a --% difference. The market reacted with a +2.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 9.81 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
What were Cytosorbents Corp.'s earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Cytosorbents Corp. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Cytosorbents Corp.'s Q4 2026 earnings?
The stock price moved up 2.6%, changed from $0.64 before the earnings release to $0.66 the day after.
When is Cytosorbents Corp. expected to report next?
The next earning report is scheduled for 01. März 2026.
What are the forecasts for Cytosorbents Corp.'s next earnings report?
Based on 5
analysts, Cytosorbents Corp. is expected to report EPS of -$0.04 and revenue of $9.81M for Q4 2025.